Tag Archives: U.S.

U.S. Pharmacy Chains Take on Cancer

Most Americans associate pharmacies with prescription drugs, vitamins and other over-the-counter remedies. But over the past few years, pharmacies have increasingly been including cancer care and prevention among their services, signaling a trend that could disrupt health care industry. Forbes reports that Walgreens has announced a first-of-its kind program called Feel More Like You, which… Read More »

Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma

Print this page ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved Cabometyx (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. HCC is the most common form of liver cancer and the fastest-rising cause of cancer-related death in… Read More »

Viewpoints: Simplify Regulations That Keep Diagnostic Innovations Out Of Hands Of U.S. Physicians; New Opioid Policies Bring Harm To Patients Who Need Them

Editorial writers focus on these health topics and others. Stat: Diagnostic Innovations Are Slowed By Bureaucratic Roadblocks Imagine, for a minute, that you are a cardiologist working in the emergency department of a busy hospital. You have several patients with chest pain: some of them are having heart attacks, or are about to; others have… Read More »